SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000812796-06-000067
Filing Date
2006-12-01
Accepted
2006-12-01 15:02:19
Documents
4
Period of Report
2006-12-01

Document Format Files

Seq Description Document Type Size
1 DOR PRE 14A - PROXY 120106 pre14a120106.htm PRE 14A 316733
3 STOCK stock.jpg GRAPHIC 71465
4 DOR dor.jpg GRAPHIC 12259
5 filename5.htm CORRESP 4994
  Complete submission text file 0000812796-06-000067.txt   439028
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-16929 | Film No.: 061250920
SIC: 2834 Pharmaceutical Preparations